Bridging the gap between target-based and phenotypic-based drug discovery-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bridging the gap between target-based and phenotypic-based drug discovery

Published:2024-05-15 Issue:7 Volume:19 Page:789-798
ISSN:1746-0441
Container-title:Expert Opinion on Drug Discovery
language:en
Short-container-title:Expert Opinion on Drug Discovery

Author:

Calado Cecília R.C.¹²^ORCID

Affiliation:

1. ISEL-Instituto Superior de Engenharia de Lisboa, Instituto Politécnico de Lisboa, Lisboa, Portugal

2. iBB – Institute for Bioengineering and Biosciences, i4HB – The Associate Laboratory Institute for Health and Bioeconomy, IST – Instituto Superior Técnico, Universidade de Lisboa, Lisbon, Portugal

Funder

Fundação para a Ciência e a Tecnologia

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/17460441.2024.2355330

Reference72 articles.

1. Rational design of potent sialidase-based inhibitors of influenza virus replication

2. Antibiotic Discovery: Where Have We Come from, Where Do We Go?

3. Hypocholesterolemic activity of a novel inhibitor of cholesterol absorption, SCH 48461

4. The role of serendipity in drug discovery

5. Memantine: update on the current evidence

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PROTAC technology: From drug development to probe technology for target deconvolution;European Journal of Medicinal Chemistry;2024-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP